STOCK TITAN

[Form 4] Zai Lab Limited American Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 06/18/2025, Zai Lab Limited (ticker: ZLAB) reported a director share transaction in a Form 4 filing. Director Richard Gaynor received 10,831 American Depositary Shares (ADS)—each ADS represents ten ordinary shares—under transaction code A (acquisition) at a price of $0, indicating a restricted share award rather than an open-market purchase.

After the grant, Gaynor’s total beneficial ownership rose to 54,899 ADS. The award will vest in full on 06/18/2026, contingent upon his continued board service. No derivative securities were involved and no shares were sold. The filing underscores ongoing equity-based compensation to align director incentives with shareholder interests, with no immediate cash impact on Zai Lab’s financials.

Il 18/06/2025, Zai Lab Limited (ticker: ZLAB) ha comunicato una transazione azionaria di un amministratore tramite un modulo Form 4. L'amministratore Richard Gaynor ha ricevuto 10.831 American Depositary Shares (ADS)—ogni ADS rappresenta dieci azioni ordinarie—con il codice transazione A (acquisizione) a un prezzo di $0, indicando un premio azionario vincolato piuttosto che un acquisto sul mercato aperto.

Dopo l'assegnazione, la proprietà effettiva di Gaynor è salita a 54.899 ADS. Il premio sarà interamente maturato il 18/06/2026, subordinatamente alla sua continuazione nel consiglio di amministrazione. Non sono stati coinvolti strumenti derivati né sono state vendute azioni. La comunicazione evidenzia una compensazione basata su azioni per allineare gli incentivi degli amministratori con gli interessi degli azionisti, senza impatto immediato in contanti sui bilanci di Zai Lab.

El 18/06/2025, Zai Lab Limited (símbolo: ZLAB) reportó una transacción accionaria de un director mediante un formulario Form 4. El director Richard Gaynor recibió 10,831 American Depositary Shares (ADS)—cada ADS representa diez acciones ordinarias—bajo el código de transacción A (adquisición) a un precio de $0, lo que indica una concesión de acciones restringidas en lugar de una compra en el mercado abierto.

Tras la concesión, la propiedad beneficiaria total de Gaynor aumentó a 54,899 ADS. La concesión se consolidará por completo el 18/06/2026, condicionado a su continuidad en el consejo. No se involucraron valores derivados ni se vendieron acciones. El informe subraya la compensación basada en acciones para alinear los incentivos de los directores con los intereses de los accionistas, sin impacto inmediato en efectivo para las finanzas de Zai Lab.

2025년 6월 18일, Zai Lab Limited(티커: ZLAB)는 Form 4 신고를 통해 이사의 주식 거래를 보고했습니다. 이사 Richard Gaynor는 거래 코드 A(취득)로 10,831 미국예탁증서(ADS)를 받았으며, 각 ADS는 보통주 10주를 나타내고, 가격은 $0로 제한된 주식 수여임을 의미합니다.

수여 후 Gaynor의 총 실소유 주식은 54,899 ADS로 증가했습니다. 이 수여분은 2026년 6월 18일에 전액 완성되며, 이사의 계속된 이사회 근무가 조건입니다. 파생증권은 포함되지 않았고 주식 매도도 없었습니다. 이번 신고는 이사의 인센티브를 주주 이익과 일치시키기 위한 주식 기반 보상을 강조하며, Zai Lab의 재무에 즉각적인 현금 영향은 없습니다.

Le 18/06/2025, Zai Lab Limited (symbole : ZLAB) a déclaré une transaction d’actions d’un administrateur dans un dépôt Form 4. L’administrateur Richard Gaynor a reçu 10 831 American Depositary Shares (ADS)—chaque ADS représentant dix actions ordinaires—sous le code de transaction A (acquisition) au prix de 0 $, indiquant une attribution d’actions restreintes plutôt qu’un achat sur le marché libre.

Après l’attribution, la propriété bénéficiaire totale de Gaynor est montée à 54 899 ADS. L’attribution sera entièrement acquise le 18/06/2026, sous réserve de sa poursuite au sein du conseil d’administration. Aucun titre dérivé n’a été impliqué et aucune action vendue. Le dépôt souligne une rémunération continue basée sur des actions visant à aligner les incitations des administrateurs avec les intérêts des actionnaires, sans impact immédiat en trésorerie sur les finances de Zai Lab.

Am 18.06.2025 meldete Zai Lab Limited (Ticker: ZLAB) eine Direktoren-Aktientransaktion in einer Form 4-Einreichung. Direktor Richard Gaynor erhielt 10.831 American Depositary Shares (ADS)—wobei jede ADS zehn Stammaktien repräsentiert—unter dem Transaktionscode A (Erwerb) zu einem Preis von $0, was auf eine beschränkte Aktienzuteilung statt eines offenen Markt-Kaufs hinweist.

Nach der Zuteilung stieg Gaynors Gesamtbeteiligung auf 54.899 ADS. Die Zuteilung wird am 18.06.2026 vollständig fällig, vorbehaltlich seiner fortgesetzten Tätigkeit im Vorstand. Es waren keine Derivate beteiligt und keine Aktien wurden verkauft. Die Meldung unterstreicht eine laufende aktienbasierte Vergütung, um die Anreize der Direktoren mit den Interessen der Aktionäre in Einklang zu bringen, ohne unmittelbare Barwirkung auf die Finanzen von Zai Lab.

Positive
  • Insider acquisition: Director Richard Gaynor received 10,831 restricted ADS, increasing his stake to 54,899 ADS and reinforcing alignment with shareholders.
Negative
  • None.

Insights

TL;DR: Routine restricted-share grant; minimal dilution, neutral near-term impact.

The 10,831-ADS grant equals roughly one year of board compensation and raises insider holdings to 54,899 ADS. Because the shares vest after a one-year service period and were issued at no cost, dilution is de minimis relative to Zai Lab’s outstanding share count. There are no sales or derivative exercises, so the transaction does not signal opportunistic profit-taking. From a valuation standpoint, the event is immaterial and does not alter earnings forecasts, but it modestly strengthens director–shareholder alignment.

TL;DR: Equity grant improves board alignment; positive governance signal.

Providing directors with time-based restricted stock is a best-practice governance approach that links oversight incentives to long-term value creation. The one-year vesting cliff encourages continued engagement while avoiding excessive short-term risk-taking. Although the size of the grant is not large enough to materially change ownership structure, the fact that Gaynor now holds nearly 55k ADS strengthens independence and commitment. No red flags or unusual patterns are evident.

Il 18/06/2025, Zai Lab Limited (ticker: ZLAB) ha comunicato una transazione azionaria di un amministratore tramite un modulo Form 4. L'amministratore Richard Gaynor ha ricevuto 10.831 American Depositary Shares (ADS)—ogni ADS rappresenta dieci azioni ordinarie—con il codice transazione A (acquisizione) a un prezzo di $0, indicando un premio azionario vincolato piuttosto che un acquisto sul mercato aperto.

Dopo l'assegnazione, la proprietà effettiva di Gaynor è salita a 54.899 ADS. Il premio sarà interamente maturato il 18/06/2026, subordinatamente alla sua continuazione nel consiglio di amministrazione. Non sono stati coinvolti strumenti derivati né sono state vendute azioni. La comunicazione evidenzia una compensazione basata su azioni per allineare gli incentivi degli amministratori con gli interessi degli azionisti, senza impatto immediato in contanti sui bilanci di Zai Lab.

El 18/06/2025, Zai Lab Limited (símbolo: ZLAB) reportó una transacción accionaria de un director mediante un formulario Form 4. El director Richard Gaynor recibió 10,831 American Depositary Shares (ADS)—cada ADS representa diez acciones ordinarias—bajo el código de transacción A (adquisición) a un precio de $0, lo que indica una concesión de acciones restringidas en lugar de una compra en el mercado abierto.

Tras la concesión, la propiedad beneficiaria total de Gaynor aumentó a 54,899 ADS. La concesión se consolidará por completo el 18/06/2026, condicionado a su continuidad en el consejo. No se involucraron valores derivados ni se vendieron acciones. El informe subraya la compensación basada en acciones para alinear los incentivos de los directores con los intereses de los accionistas, sin impacto inmediato en efectivo para las finanzas de Zai Lab.

2025년 6월 18일, Zai Lab Limited(티커: ZLAB)는 Form 4 신고를 통해 이사의 주식 거래를 보고했습니다. 이사 Richard Gaynor는 거래 코드 A(취득)로 10,831 미국예탁증서(ADS)를 받았으며, 각 ADS는 보통주 10주를 나타내고, 가격은 $0로 제한된 주식 수여임을 의미합니다.

수여 후 Gaynor의 총 실소유 주식은 54,899 ADS로 증가했습니다. 이 수여분은 2026년 6월 18일에 전액 완성되며, 이사의 계속된 이사회 근무가 조건입니다. 파생증권은 포함되지 않았고 주식 매도도 없었습니다. 이번 신고는 이사의 인센티브를 주주 이익과 일치시키기 위한 주식 기반 보상을 강조하며, Zai Lab의 재무에 즉각적인 현금 영향은 없습니다.

Le 18/06/2025, Zai Lab Limited (symbole : ZLAB) a déclaré une transaction d’actions d’un administrateur dans un dépôt Form 4. L’administrateur Richard Gaynor a reçu 10 831 American Depositary Shares (ADS)—chaque ADS représentant dix actions ordinaires—sous le code de transaction A (acquisition) au prix de 0 $, indiquant une attribution d’actions restreintes plutôt qu’un achat sur le marché libre.

Après l’attribution, la propriété bénéficiaire totale de Gaynor est montée à 54 899 ADS. L’attribution sera entièrement acquise le 18/06/2026, sous réserve de sa poursuite au sein du conseil d’administration. Aucun titre dérivé n’a été impliqué et aucune action vendue. Le dépôt souligne une rémunération continue basée sur des actions visant à aligner les incitations des administrateurs avec les intérêts des actionnaires, sans impact immédiat en trésorerie sur les finances de Zai Lab.

Am 18.06.2025 meldete Zai Lab Limited (Ticker: ZLAB) eine Direktoren-Aktientransaktion in einer Form 4-Einreichung. Direktor Richard Gaynor erhielt 10.831 American Depositary Shares (ADS)—wobei jede ADS zehn Stammaktien repräsentiert—unter dem Transaktionscode A (Erwerb) zu einem Preis von $0, was auf eine beschränkte Aktienzuteilung statt eines offenen Markt-Kaufs hinweist.

Nach der Zuteilung stieg Gaynors Gesamtbeteiligung auf 54.899 ADS. Die Zuteilung wird am 18.06.2026 vollständig fällig, vorbehaltlich seiner fortgesetzten Tätigkeit im Vorstand. Es waren keine Derivate beteiligt und keine Aktien wurden verkauft. Die Meldung unterstreicht eine laufende aktienbasierte Vergütung, um die Anreize der Direktoren mit den Interessen der Aktionäre in Einklang zu bringen, ohne unmittelbare Barwirkung auf die Finanzen von Zai Lab.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GAYNOR RICHARD

(Last) (First) (Middle)
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zai Lab Ltd [ ZLAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
American Depositary Shares(1) 06/18/2025 A 10,831(2) A $0 54,899 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
2. Represents restricted shares that vest in full on June 18, 2026, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date.
/s/ Bruce Blefeld, Attorney-in-Fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zai Lab (ZLAB) disclose in the latest Form 4?

Director Richard Gaynor was granted 10,831 restricted ADS on 06/18/2025 at a cost of $0.

How many ZLAB shares does Richard Gaynor now own?

Following the grant, Gaynor beneficially owns 54,899 ADS.

When do the newly granted ZLAB restricted shares vest?

The ADS award will vest in full on 06/18/2026, subject to continued board service.

Were any ZLAB shares sold in this Form 4 filing?

No. The filing only reports an acquisition of restricted shares; no dispositions were made.

Does the Form 4 involve any derivative securities?

No derivative securities were acquired or disposed of in this filing.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

3.73B
108.88M
1.41%
42.64%
4.16%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI